Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia resulting in visceral arteriovenous malformations and smaller mucocutaneous telangiectasia. Most patients experience recurrent nosebleeds and become anemic without iron supplementation. However, thousands may requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Shovlin, C. L., Millar, C. M., Droege, F., Kjeldsen, A., Manfredi, G., Suppressa, P., Ugolini, S., Coote, N., Fialla, A. D., Geisthoff, U., Lenato, G. M., Mager, H. J., Pagella, F., Post, M. C., Sabbà, C., Sure, U., Torring, P. M., Dupuis-Girod, S., Buscarini, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714298/
https://www.ncbi.nlm.nih.gov/pubmed/31462308
http://dx.doi.org/10.1186/s13023-019-1179-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714298/
https://www.ncbi.nlm.nih.gov/pubmed/31462308
http://dx.doi.org/10.1186/s13023-019-1179-1

Ejemplares similares